Dodge & Cox Regeneron Pharmaceuticals, Inc. Transaction History

Dodge & Cox

$165 Billion
Q3 2024

A detailed history of Dodge & Cox transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Dodge & Cox holds 2,311,935 shares of REGN stock, worth $1.62 Billion. This represents 1.47% of its overall portfolio holdings.

Number of Shares

2,311,935

Previous 2,315,686 0.16%

Holding current value

$1.62 Billion

Previous $2.43 Billion 0.14%

% of portfolio

1.47%

Previous 1.53%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1024.09 - $1201.76 $3.84 Million - $4.51 Million	-3,751 Reduced 0.16%	2,311,935 $2.43 Billion
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $39 Million - $47.3 Million	-44,178 Reduced 1.87%	2,315,686 $2.43 Billion
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $7.06 Million - $7.76 Million	-7,816 Reduced 0.33%	2,359,864 $2.27 Billion
Q4 2023 Feb 15, 2024	SELL	$775.18 - $881.7 $4.12 Million - $4.69 Million	-5,318 Reduced 0.22%	2,367,680 $2.08 Billion
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $14.8 Million - $18 Million	-21,357 Reduced 0.89%	2,372,998 $1.95 Billion
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $6.76 Million - $8.02 Million	9,654 Added 0.4%	2,394,355 $1.72 Billion
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $110 Million - $134 Million	161,642 Added 7.27%	2,384,701 $1.96 Billion
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $44.8 Million - $48.6 Million	-63,450 Reduced 2.77%	2,223,059 $1.6 Billion
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $12.2 Million - $15.3 Million	21,175 Added 0.93%	2,286,509 $1.58 Billion
Q2 2022 Aug 12, 2022	BUY	$548.35 - $738.84 $15.5 Million - $20.9 Million	28,271 Added 1.26%	2,265,334 $1.34 Billion
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $1.17 Billion - $1.37 Billion	1,957,941 Added 701.46%	2,237,063 $1.56 Billion
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $152 Million - $187 Million	279,122 New	279,122 $176 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dodge & Cox, based on Form 13F filings with the SEC.

News

Stay updated on Dodge & Cox with notifications on news.

Account